Report Thumbnail
Product Code IW091401844HIU
Published Date 2021/12/14
English153 PagesAsia Pacific

ASIA-PACIFIC COSMETIC SURGERY AND PROCEDURE MARKET FORECAST 2022-2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code IW091401844HIU◆The Dec 2025 edition is also likely available. We will check with the publisher immediately.
Published Date 2021/12/14
English 153 PagesAsia Pacific

ASIA-PACIFIC COSMETIC SURGERY AND PROCEDURE MARKET FORECAST 2022-2030Pharmaceutical_LifeSciense Market



Abstract


Summary

KEY FINDINGS The Asia-Pacific cosmetic surgery and procedure market is anticipated to progress with a CAGR of 5.74% across the forecasted period of 2022 to 2030. The market growth of the region is ascribed to an increase in the aging population, the rising number of cosmetic clinics in developing economies, the rising number of cosmetic clinics in emerging economies, and the surging healthcare expenditure. MARKET INSIGHTS The Asia-Pacific cosmetic surgery and procedure market growth evaluation encompasses the assessment of South Korea, Myanmar, Japan, China, Vietnam, Indonesia, Thailand, India, Australia & New Zealand, and Rest of Asia-Pacific. The popularity of cosmetic procedures in India has significantly increased over recent years on account of the rising aging population, the prevalence of obesity, exposure to the internet, and the increasing influence of western culture. Since the nation has a tropical climate, the impact of global warming and sun damage is significantly high, thus augmenting the demand for anti-aging treatments. As per the statistics issued by the Australasian College of Cosmetic Surgery, in 2018, Australians spent significantly on cosmetic procedures per capita than the United States. The top five popular procedures recorded in Australia include anti-wrinkle injection, fillers, laser and Intense Pulsed Light (IPL), breast augmentation and reduction, and liposuction. As a result, these factors are set to reinforce the cosmetic surgery and procedure market in the Asia-Pacific during the forecasting years. COMPETITIVE INSIGHTS Some of the leading companies operating in the market are Alma Lasers Ltd, Candela Corp, Johnson & Johnson, etc. Our report offerings include: • Explore key findings of the overall market • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges) • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions • Market Segmentation cater to a thorough assessment of key segments with their market estimations • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc. • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc. • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of Contents

  • 1 RESEARCH SCOPE & METHODOLOGY

    • 1.1 STUDY OBJECTIVES
    • 1.2 SCOPE OF STUDY
    • 1.3 METHODOLOGY
    • 1.4 ASSUMPTIONS & LIMITATIONS
  • 2 EXECUTIVE SUMMARY

    • 2.1 MARKET SIZE & ESTIMATES
    • 2.2 MARKET OVERVIEW
  • 3 MARKET DYNAMICS

    • 3.1 KEY DRIVERS
      • 3.1.1 AGING POPULATION LEADS TO AN INCREASED DEMAND FOR ANTI-AGING COSMETIC AND AESTHETIC TREATMENTS
      • 3.1.2 RAPID GROWTH OF THE AESTHETIC INDUSTRY
      • 3.1.3 MEDICAL TOURISM IN DEVELOPING MARKETS
      • 3.1.4 PREFERENCE FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES OVER INVASIVE PROCEDURES
    • 3.2 KEY RESTRAINTS
      • 3.2.1 HIGH RATE OF AESTHETIC USAGES AND IMPLANTABLE MEDICAL DEVICES
      • 3.2.2 DIFFICULTIES RELATED TO COSMETIC TREATMENT
      • 3.2.3 SAFETY CONCERNS RELATED TO BREAST IMPLANT
  • 4 KEY ANALYTICS

    • 4.1 IMPACT OF COVID-19 ON COSMETIC SURGERY AND PROCEDURE MARKET
    • 4.2 KEY MARKET TRENDS
    • 4.3 PORTER’S FIVE FORCES ANALYSIS
      • 4.3.1 BUYER’S POWER
      • 4.3.2 SUPPLIER’S POWER
      • 4.3.3 NEW ENTRY
      • 4.3.4 SUBSTITUTIONS
      • 4.3.5 INDUSTRY RIVALRY
    • 4.4 VALUE CHAIN ANALYSIS
    • 4.5 REGULATORY FRAMEWORK
    • 4.6 OPPORTUNITY MATRIX
    • 4.7 VENDOR LANDSCAPE
  • 5 MARKET BY TYPE

    • 5.1 SURGICAL
      • 5.1.1 BREAST AUGMENTATION
      • 5.1.2 LIPOSUCTION
        • 5.1.2.1 LASER ASSISTED LIPOSUCTION
        • 5.1.2.2 RADIO FREQUENCY ASSISTED LIPOSUCTION
        • 5.1.2.3 ULTRASOUND ASSISTED LIPOSUCTION
        • 5.1.2.4 OTHER LIPOSUCTION SURGERIES
      • 5.1.3 EYELID SURGERY
      • 5.1.4 TUMMY TUCK
      • 5.1.5 BREAST LIFT
      • 5.1.6 OTHER SURGICAL TYPES
    • 5.2 NON-SURGICAL
      • 5.2.1 BOTULINUM TOXIN
      • 5.2.2 DERMAL FILLERS
      • 5.2.3 LASER HAIR REMOVAL
      • 5.2.4 CHEMICAL PEEL
      • 5.2.5 MICRODERMABRASION
      • 5.2.6 PHOTO-REJUVENATION
      • 5.2.7 OTHER NON-SURGICAL TYPES
  • 6 GEOGRAPHICAL ANALYSIS

    • 6.1 ASIA-PACIFIC
      • 6.1.1 MARKET SIZE & ESTIMATES
      • 6.1.2 KEY GROWTH ENABLERS
      • 6.1.3 KEY CHALLENGES
      • 6.1.4 KEY PLAYERS
      • 6.1.5 COUNTRY ANALYSIS
        • 6.1.5.1 CHINA
        • 6.1.5.2 JAPAN
        • 6.1.5.3 INDIA
        • 6.1.5.4 AUSTRALIA & NEW ZEALAND
        • 6.1.5.5 SOUTH KOREA
        • 6.1.5.6 THAILAND
        • 6.1.5.7 INDONESIA
        • 6.1.5.8 VIETNAM
        • 6.1.5.9 MYANMAR
        • 6.1.5.10 REST OF ASIA-PACIFIC
  • 7 COMPETITIVE LANDSCAPE

    • 7.1 KEY STRATEGIC DEVELOPMENTS
      • 7.1.1 MERGERS & ACQUISITIONS
      • 7.1.2 PRODUCT LAUNCHES & DEVELOPMENTS
      • 7.1.3 PARTNERSHIPS & AGREEMENTS
      • 7.1.4 BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
    • 7.2 COMPANY PROFILES
      • 7.2.1 ALLERGAN PLC (ACQUIRED BY ABBVIE)
      • 7.2.2 ALMA LASERS LTD (ACQUIRED BY FOSUN PHARMA)
      • 7.2.3 BAUSCH HEALTH COMPANIES INC (FORMERLY VALEANT PHARMACEUTICALS)
      • 7.2.4 CANDELA CORP (FORMERLY SYNERON MEDICAL LTD)
      • 7.2.5 CUTERA INC
      • 7.2.6 CYNOSURE (ACQUIRED BY CLAYTON, DUBILIER & RICE)
      • 7.2.7 GALDERMA (ACQUIRED BY EQT)
      • 7.2.8 IPSEN SA
      • 7.2.9 JOHNSON & JOHNSON
      • 7.2.10 LUMENIS LTD
      • 7.2.11 MERZ PHARMA
      • 7.2.12 SIENTRA INC
      • 7.2.13 SINCLAIR PHARMA PLC
USD 1,600 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.
ASIA-PACIFIC COSMETIC SURGERY AND PROCEDURE MARKET FORECAST 2022-2030 | Pharmaceutical_LifeSciense Market Research Report - ShareFair Markets